Literature DB >> 15117321

Prevention of hepatitis C virus infection.

M Kew1, G François, D Lavanchy, H Margolis, P Van Damme, P Grob, J Hallauer, D Shouval, G Leroux-Roels, A Meheus.   

Abstract

In spite of advances made in our understanding of the biology of the hepatitis C virus (HCV), the epidemiology and natural history of HCV infection, and the treatment of chronic hepatitis C, the development and worldwide implementation of a comprehensive prevention and control strategy remains necessary. A World Health Organization informal consultation with the Viral Hepatitis Prevention Board was convened and met in Geneva, Switzerland, 13-14 May 2002, to review epidemiological and public health aspects of HCV infection, and the various prevention and control strategies that are currently in place. Based on the presentations and discussions, a number of specific recommendations were made, which should be considered in conjunction with previously published recommendations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117321     DOI: 10.1111/j.1365-2893.2004.00492.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  11 in total

1.  Collection of social determinant of health measures in U.S. national surveillance systems for HIV, viral hepatitis, STDs, and TB.

Authors:  Victoria M Beltran; Kathleen McDavid Harrison; H Irene Hall; Hazel D Dean
Journal:  Public Health Rep       Date:  2011 Sep-Oct       Impact factor: 2.792

2.  Risk of hepatitis B and C infections in Tehranian wrestlers.

Authors:  Ramin Kordi; Keith Neal; Ali Akbar Pourfathollah; Mohammad Ali Mansournia; W Angus Wallace
Journal:  J Athl Train       Date:  2011 Jul-Aug       Impact factor: 2.860

3.  Hepatocellular carcinoma in developing countries: Prevention, diagnosis and treatment.

Authors:  Michael C Kew
Journal:  World J Hepatol       Date:  2012-03-27

4.  Purification and application of C-terminally truncated hepatitis C virus E1 proteins expressed in Escherichia coli.

Authors:  Jing Liu; Li-Xin Zhu; Yu-Ying Kong; Guang-Di Li; Yuan Wang
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

Review 5.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18

6.  Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.

Authors:  Bo Jin; Richard Y Wang; Qi Qiu; Fuminaka Sugauchi; Teresa Grandinetti; Harvey J Alter; J Wai-Kuo Shih
Journal:  Immunology       Date:  2007-04-23       Impact factor: 7.397

7.  Hepatitis C Virus infection in apparentenly healthy individuals with family history of diabetes in Vom, Plateau State Nigeria.

Authors:  Obinna O Nwankiti; James A Ndako; Georgebest On Echeonwu; Atanda O Olabode; Chika I Nwosuh; Ema M Onovoh; Lilian A Okeke; Jumoke O Akinola; Boniface N Duru; Ijeoma O Nwagbo; Godwin O Agada; Anthony A Chukwuedo
Journal:  Virol J       Date:  2009-07-20       Impact factor: 4.099

8.  HCV Infection Frequency and Trends Among Voluntary Blood Donors in Cluj County (Romania) Between 2006 and 2011.

Authors:  Giorgiana HâȚu; Irina Maria Brumboiu; Ioan Stelian BocȘan
Journal:  Clujul Med       Date:  2014-08-05

9.  Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study.

Authors:  Abdul Majeed Akhtar; Sadia Majeed; Muhammad Jamil; Abdul Rehman; Sufia Majeed
Journal:  Pak J Med Sci       Date:  2016 Mar-Apr       Impact factor: 1.088

Review 10.  Hepatocellular carcinoma: epidemiology and risk factors.

Authors:  Michael C Kew
Journal:  J Hepatocell Carcinoma       Date:  2014-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.